Piezoelectric Sensor Measures Antibiotic Efficacy
By HospiMedica International staff writers Posted on 25 Oct 2017 |
Image: Dr. Ward Johnson observes signals generated by bacteria coating quartz crystals (Photo courtesy of Burrus / NIST.
A new study claims that a quartz-based sensor could determine within an hour if an antibiotic will be effective against an infection.
The novel piezoelectric resonator, developed by researchers at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), is extremely sensitive, and can detect the mechanical motion of microbes adhered to it, and their response to antibiotics. The sensor is composed of a thin piezoelectric quartz disk sandwiched between two electrodes. An alternating voltage at a stable frequency--near the crystal's resonant frequency--is applied to one electrode to excite crystal vibrations.
At the other electrode (on the opposite side of the crystal), oscillating voltages resulting from crystal response can be recorded; the fluctuations in the resonant frequency result from microbial mechanical activity of the several million bacterial cells coupled to the crystal surface. The ultra-sensitive approach can enable detection of cell-generated frequency fluctuations at a level of less than one part in 10 billion, with the amount of frequency noise generated correlating with the density of the living bacterial cells.
When E. coli bacteria were exposed to different antibiotics, the sensor showed that the frequency noise from the bacteria fell to zero within seven minutes of being treated with polymyxin B, and within 15 minutes of receiving ampicillin; the results mirrored the normal pharmacokinetics of the antibiotic drugs. The researchers added that since they used bacteria with paralyzed flagella, they concluded that the frequency fluctuations resulted from vibrations of cell walls. The study was published on September 22, 2017, in Nature Scientific Reports.
“Current tests require colonies of bacteria to be cultured for days, which can allow an improperly treated infection to advance and give the bacteria a chance to develop drug resistance,” concluded lead author Ward Johnson, PhD. “The NIST sensor is a quartz-crystal resonator that vibrates differently when bacterial cells on its surface change their behavior; it detects the mechanical motion of microbes to gauge a response to antibiotics…the amount of frequency noise emitted by the bacterial cells increased with the density of bacteria.”
Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1%. Conversely, the same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.
Related Links:
National Institute of Standards and Technology
The novel piezoelectric resonator, developed by researchers at the U.S. National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), is extremely sensitive, and can detect the mechanical motion of microbes adhered to it, and their response to antibiotics. The sensor is composed of a thin piezoelectric quartz disk sandwiched between two electrodes. An alternating voltage at a stable frequency--near the crystal's resonant frequency--is applied to one electrode to excite crystal vibrations.
At the other electrode (on the opposite side of the crystal), oscillating voltages resulting from crystal response can be recorded; the fluctuations in the resonant frequency result from microbial mechanical activity of the several million bacterial cells coupled to the crystal surface. The ultra-sensitive approach can enable detection of cell-generated frequency fluctuations at a level of less than one part in 10 billion, with the amount of frequency noise generated correlating with the density of the living bacterial cells.
When E. coli bacteria were exposed to different antibiotics, the sensor showed that the frequency noise from the bacteria fell to zero within seven minutes of being treated with polymyxin B, and within 15 minutes of receiving ampicillin; the results mirrored the normal pharmacokinetics of the antibiotic drugs. The researchers added that since they used bacteria with paralyzed flagella, they concluded that the frequency fluctuations resulted from vibrations of cell walls. The study was published on September 22, 2017, in Nature Scientific Reports.
“Current tests require colonies of bacteria to be cultured for days, which can allow an improperly treated infection to advance and give the bacteria a chance to develop drug resistance,” concluded lead author Ward Johnson, PhD. “The NIST sensor is a quartz-crystal resonator that vibrates differently when bacterial cells on its surface change their behavior; it detects the mechanical motion of microbes to gauge a response to antibiotics…the amount of frequency noise emitted by the bacterial cells increased with the density of bacteria.”
Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1%. Conversely, the same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.
Related Links:
National Institute of Standards and Technology
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration